| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146990 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 07/29/2004 | US20040146988 Interferon-like protein zcyto21 |
| 07/29/2004 | US20040146986 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 07/29/2004 | US20040146976 Transforming microorganism and monitoring expression of heterologous proteins on cell surface; monitoring protein-protein interactions and identifying modulators for treating autoimmune and cell proliferative diseases |
| 07/29/2004 | US20040146972 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/29/2004 | US20040146963 High throughput assays for the proteotytic activities of clostridial neurotoxins |
| 07/29/2004 | US20040146959 for detecting the phosphorylation activity of one or more protein kinases in a sample; fluorescent dye linked phosphorylable substrate |
| 07/29/2004 | US20040146958 Glucose strip sensor and glucose measurement using the glucose strip sensor |
| 07/29/2004 | US20040146957 Biosensor |
| 07/29/2004 | US20040146956 Protease efc cell surface fusion protein assay |
| 07/29/2004 | US20040146954 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 07/29/2004 | US20040146953 Assay |
| 07/29/2004 | US20040146952 T cell receptors mutants that have higher affinity for the peptide/MHC ligand than the wild type; can be used in place of an antibody or single chain antibody |
| 07/29/2004 | US20040146951 from pancreas cells; for drug screening compounds that also bind to somatostatin type-5 receptor ("SSTR-5") |
| 07/29/2004 | US20040146950 Phosphoprotein detection reagent and methods of making and using the same |
| 07/29/2004 | US20040146949 contacting a first sample of cells with CD40 ligand and measuring the level or amount of a marker; contacting a second sample of cells with a compound and CD40 ligand and measuring the level or amount of a marker; comparing level of marker in both |
| 07/29/2004 | US20040146947 Inflammatory bowel disease: noninvasive diagnosis |
| 07/29/2004 | US20040146946 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146945 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146944 for drug screening/targets in vivo; protein-transduction domains; genetic engineering; kits |
| 07/29/2004 | US20040146943 Novel composition and use as matrix in MALDI-TOF-MS |
| 07/29/2004 | US20040146941 Chemical encoding technology for combinatorial synthesis |
| 07/29/2004 | US20040146940 Cripto blocking antibodies and uses thereof |
| 07/29/2004 | US20040146937 Protein interaction difference mapping |
| 07/29/2004 | US20040146936 System and method for identifying cellular pathways and interactions |
| 07/29/2004 | US20040146935 Disease associated gene |
| 07/29/2004 | US20040146934 Multi-functional antibodies |
| 07/29/2004 | US20040146933 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/29/2004 | US20040146931 for detecting protein-protein, protein-DNA, or protein-RNA interactions; for drug screening or screening libraries with greater than 107 members; used in conjunction with flow cytometry; solid phase synthesis; kits |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146926 Chemokine receptor |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146920 capable of efficiently preventing the nonspecific binding of a target material even when a compound such as a blocking material is not used |
| 07/29/2004 | US20040146919 comprises staining tissues and genetic analysis to determine whether the DNA of such sites exhibits allelic losses for mutation of tumor suppressor genes; genetic engineering |
| 07/29/2004 | US20040146918 Hybrid nucleic acid assembly |
| 07/29/2004 | US20040146917 Nanoparticle imaging system and method |
| 07/29/2004 | US20040146911 Method for the uncoupled, direct, exponential amplification and sequencing of DNA molecules with the addition of a second thermostable DNA polymerase and its application |
| 07/29/2004 | US20040146909 comprises array with a plurality of electrodes, a capture binding ligand covalently attached to the electrode, a target analyte, and an electron; for higher signal to noise ratios/detection limits; includes monitoring at higher harmonic frequencies |
| 07/29/2004 | US20040146907 Methods and compositions for detecting dysplasia |
| 07/29/2004 | US20040146903 Methods and compositions for modulating activator protein 1 |
| 07/29/2004 | US20040146900 Using presence/absence of polymorphism in ataxia polypeptide and/or genes to diagnose myoclonus, dystonia, epilepsy and nystagmus |
| 07/29/2004 | US20040146899 Recovering and analyzing blood using monolayers comprised of insulators and/or electroconduit-forming species; nucleic acid and protein screening; diagnosing infection |
| 07/29/2004 | US20040146896 Methods and compositions for diagnosing and treating companion animal cancer |
| 07/29/2004 | US20040146893 Nucleotide sequences coding heterologous polypeptide for use in diagnosis and treatment of nervous system, cell proliferative, inflammatory and autoimmune diseases; wound healing agents |
| 07/29/2004 | US20040146892 Expression vector coding organelle transport protein for use in identifying modulators of adenine nucleotide translocator and cyclophilin d interaction |
| 07/29/2004 | US20040146891 Comprises growth factor for diagnosis and treatment of immunological and cell proliferative disorders |
| 07/29/2004 | US20040146889 Inducible regulatory system and use thereof |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146885 Multiplexing array techniques |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146879 Novel human genes and gene expression products |
| 07/29/2004 | US20040146878 Identifying muscular disorder using amplified mutant gene sequences; genetic mapping |
| 07/29/2004 | US20040146877 Diagnosis and treatment of cancer:I |
| 07/29/2004 | US20040146876 Complex element micro-array and methods of use |
| 07/29/2004 | US20040146875 Detecting nucleotide sequence variation between alleles/heteroduplex DNA; restriction fragment length polymorphisms |
| 07/29/2004 | US20040146874 Disposable biochip for determining nucleotide sequence beyond specified primer; DNA sequencing and analysis |
| 07/29/2004 | US20040146873 Advanced sleep phase syndrome gen in humans |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146870 Correlating phenotypic characteristic/polymorphisms with position on genetic physical map using haplotype genomes |
| 07/29/2004 | US20040146865 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 07/29/2004 | US20040146863 Electronic detection of biological molecules using thin layers |
| 07/29/2004 | US20040146861 Diagnosing and treating cancer cells using mutant viruses |
| 07/29/2004 | US20040146857 Immunoglobulin for detection, prevention, treatment and prognosis of viral infections |
| 07/29/2004 | US20040146855 Preparing ferric oxide cross-linked polysaccharide/starch/chitosan matrix for the separation, isolation, identification or purification of biological materials |
| 07/29/2004 | US20040146854 Attenuated forms of bovine viral diarrhea virus |
| 07/29/2004 | US20040146853 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 07/29/2004 | US20040146852 Methods of determining active levels of drugs in fluid samples |
| 07/29/2004 | US20040146851 Identifying compounds which modulate phosphatidylserine exposure on the surface of megakaryocytes for use in treating thrombosis, bleeding and apoptosis disorders |
| 07/29/2004 | US20040146849 Microarray for directly monitoring ion transport functions and/or property using fluorescence resonance energy transfe; diagnosing arrhythmias, cancer and nervous system disorders |
| 07/29/2004 | US20040146848 Evaluating sperm concentration, migration and velocity using synchronically pulsed light source, optical absorbance and photodetectors; in vitro fertilization and diagnosis of reproductive disorders |
| 07/29/2004 | US20040146847 Process for glucuronidation screening |
| 07/29/2004 | US20040146615 Processes for evaluating agricultural and/or food materials; applications;and, products |
| 07/29/2004 | US20040146522 For therapy of individual exposed to or infected with HIV-1 |
| 07/29/2004 | US20040146516 Lumen-exposed molecules and methods for targeted delivery |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | US20040146500 Gel with grafted biomacromolecules; diagnostic kits |
| 07/29/2004 | US20040146495 Analyzing a blood sample for secretin level |
| 07/29/2004 | US20040146460 Hyperpolarizability second-harmonic active labels; protein, viruses, nucleic acid, and cell detection |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | US20040146429 Porous substrate with one or more colorimetric indicators embedded; accurate testing of date rape drugs |
| 07/29/2004 | US20040146428 Drug screening for metabolic by-products in human urine by mounting test strip to interior of toilet bowl above flush water line; chemical on strip is activated by flush water containing urine; removal, examination |
| 07/29/2004 | US20040145725 Optical detection system for flow cytometry |
| 07/29/2004 | US20040145631 Highly parallel fabrication of microarrays by ink jet printheads |
| 07/29/2004 | US20040145379 Soil matric potential and salinity measurement apparatus and method of use |
| 07/29/2004 | US20040144948 Novel compounds for generating chemiluminescence with a peroxidase |
| 07/29/2004 | US20040144921 Method for observing high-altitude neutral air and device for observing high-altitude neutral air |
| 07/29/2004 | US20040144658 Apparatus and method for biopolymer indentification during translocation through a nanopore |
| 07/29/2004 | US20040144649 Electrophoresis |
| 07/29/2004 | US20040144645 Gas sensor with improved structure of protective cover |
| 07/29/2004 | US20040144182 Apparatus and method for providing a flow measurement compensated for entrained gas |
| 07/29/2004 | DE4321736B4 Sensoreinrichtung für oxidierbare Gase und Betriebsverfahren für die Sensoreinrichtung Sensor means oxidizable gas and operating procedures for the sensor device |
| 07/29/2004 | DE202004007013U1 Moisture content measurement apparatus, for wood sample, e.g. furniture or flooring, has microwave resonator with opening to take sample holder shrouded against escape of microwaves |
| 07/29/2004 | DE202004004525U1 pulverized coal sulfur content measuring rod has alternate luminescent sources and electron receivers for radiation reflected by sulfur particles |
| 07/29/2004 | DE10350453A1 Ölverschlechterungs-Erfassungsvorrichtung Oil deterioration-detecting device |
| 07/29/2004 | DE10303265A1 Detecting analytes by a redox reaction and fluorescent measurement, useful for diagnosis, comprises using a fluorimetric redox indicator consisting of a linked fluorophore and quencher |
| 07/29/2004 | DE10302405A1 Detecting effect of substances on beta-cell function and mass, for identifying agents for treating late stages of diabetes type II, comprises immunoblotting and mitogen-activated protein kinase and pull-down assays |
| 07/29/2004 | DE10301206A1 Water absorption measurement device, for determining the behavior of sample material, comprises a capillary tube system for delivery of water to a container held in contact with the sample |